Abstract
Galectins are a family of proteins with at least one carbohydrate-recognition domain. Galectins are present in various tissues and organs and participate in different physiological and pathological molecular reactions in vivo. Wound healing is the basic process of traumatic disease recovery. Wound healing involves three overlapping stages: inflammation, proliferation, and remodelling. Furthermore, a comparison of wound healing with the tumour microenvironment revealed that galectin plays a key role in the wound healing process. The current review describes the role of galectin in inflammation, angiogenesis, re-epithelialisation, and fibrous scar formation and evaluates its potential as a therapeutic drug for wounds.
Similar content being viewed by others
References
Brinchmann MF, Patel DM, Iversen MH (2018) The role of galectins as modulators of metabolism and inflammation. Mediators Inflamm 2018:9186940. https://doi.org/10.1155/2018/9186940
Hirabayashi J, Kasai K-i (1993) The family of metazoan metal-independent β-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology 3:297–304. https://doi.org/10.1093/glycob/3.4.297
Hughes RC (1999) Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochimica et Biophysica Acta (BBA) - General Subjects 1473:172–185. https://doi.org/10.1016/S0304-4165(99)00177-4
Stowell SR, Arthur CM, Dias-Baruffi M, Rodrigues LC, Gourdine J-P, Heimburg-Molinaro J, Ju T, Molinaro RJ, Rivera-Marrero C, Xia B et al (2010) Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 16:295–301. https://doi.org/10.1038/nm.2103
Stowell SR, Arthur CM, McBride R, Berger O, Razi N, Heimburg-Molinaro J, Rodrigues LC, Gourdine J-P, Noll AJ, von Gunten S et al (2014) Microbial glycan microarrays define key features of host-microbial interactions. Nat Chem Biol 10:470–476. https://doi.org/10.1038/nchembio.1525
Raz A, Lotan R (1987) Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 6:433–452
Sundblad V, Mathieu V, Kiss R, Rabinovich GA (2013) Chapter 31—galectins: key players in the tumor microenvironment. In: Prendergast GC, Jaffee EM (eds) Cancer Immunotherapy, 2nd edn. Academic Press, San Diego, pp 537–563
Yang R-Y, Rabinovich GA, Liu F-T (2008) Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10:e17. https://doi.org/10.1017/S1462399408000719
Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F (2002) Introduction to galectins. Glycoconj J 19:433–440. https://doi.org/10.1023/B:GLYC.0000014072.34840.04
McLeod K, Walker JT, Hamilton DW (2018) Galectin-3 regulation of wound healing and fibrotic processes: insights for chronic skin wound therapeutics. J Cell Commun Signal 12:281–287. https://doi.org/10.1007/s12079-018-0453-7
Dvořánková B, Szabo P, Lacina L, Gal P, Uhrova J, Zima T, Kaltner H, André S, Gabius HJ, Sykova E et al (2011) Human galectins induce conversion of dermal fibroblasts into myofibroblasts and production of extracellular matrix: potential application in tissue engineering and wound repair. Cells Tissues Organs 194:469–480. https://doi.org/10.1159/000324864
Panjwani N (2014) Role of galectins in re-epithelialization of wounds. Ann Transl Med 2:89–89. https://doi.org/10.3978/j.issn.2305-5839.2014.09.09
Rhodes DH, Pini M, Castellanos KJ, Montero-Melendez T, Cooper D, Perretti M, Fantuzzi G (2013) Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function. Obesity (Silver Spring) 21:310–319. https://doi.org/10.1002/oby.20016
Perillo NL, Pace KE, Seilhamer JJ, Baum LG (1995) Apoptosis of T cells mediated by galectin-1. Nature 378:736–739. https://doi.org/10.1038/378736a0
Than NG, Erez O, Wildman DE, Tarca AL, Edwin SS, Abbas A, Hotra J, Kusanovic JP, Gotsch F, Hassan SS et al (2008) Severe preeclampsia is characterized by increased placental expression of galectin-1. J Matern Fetal Neona 21:429–442. https://doi.org/10.1080/14767050802041961
Auvynet C, Moreno S, Melchy E, Coronado-Martínez I, Montiel JL, Aguilar-Delfin I, Rosenstein Y (2013) Galectin-1 promotes human neutrophil migration. Glycobiology 23:32–42. https://doi.org/10.1093/glycob/cws128
Ito K, Stannard K, Gabutero E, Clark AM, Neo S-Y, Onturk S, Blanchard H, Ralph SJ (2012) Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. Cancer Metastasis Rev 31:763–778. https://doi.org/10.1007/s10555-012-9388-2
Lei T, Moos S, Klug J, Aslani F, Bhushan S, Wahle E, Fröhlich S, Meinhardt A, Fijak M (2018) Galectin-1 enhances TNFα-induced inflammatory responses in Sertoli cells through activation of MAPK signalling. Sci Rep 8:3741–3741. https://doi.org/10.1038/s41598-018-22135-w
Kim MH, Wu WH, Choi JH, Kim J, Jun JH, Ko Y, Lee JH (2018) Galectin-1 from conditioned medium of three-dimensional culture of adipose-derived stem cells accelerates migration and proliferation of human keratinocytes and fibroblasts. Wound Repair and Regeneration 26:S9–S18. https://doi.org/10.1111/wrr.12579
Lin Y-T, Chen J-S, Wu M-H, Hsieh IS, Liang C-H, Hsu C-L, Hong T-M, Chen Y-L (2015) Galectin-1 accelerates wound healing by regulating the neuropilin-1/Smad3/NOX4 pathway and ROS production in myofibroblasts. J Investig Dermatol 135:258–268. https://doi.org/10.1038/jid.2014.288
D’Haene N, Sauvage S, Maris C, Adanja I, Le Mercier M, Decaestecker C, Baum L, Salmon I (2013) VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis. PLoS ONE 8:e67029–e67029. https://doi.org/10.1371/journal.pone.0067029
Paclik D, Danese S, Berndt U, Wiedenmann B, Dignass A, Sturm A (2008) Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS ONE 3:e2629–e2629. https://doi.org/10.1371/journal.pone.0002629
Yıldırım C, Vogel DYS, Hollander MR, Baggen JM, Fontijn RD, Nieuwenhuis S, Haverkamp A, de Vries MR, Quax PHA, Garcia-Vallejo JJ et al (2015) Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophages. PLoS ONE 10:e0124347–e0124347. https://doi.org/10.1371/journal.pone.0124347
Barrow H, Guo X, Wandall HH, Pedersen JW, Fu B, Zhao Q, Chen C, Rhodes JM, Yu L-G (2011) Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clin Cancer Res 17:7035. https://doi.org/10.1158/1078-0432.CCR-11-1462
Gendronneau G, Sidhu SS, Delacour D, Dang T, Calonne C, Houzelstein D, Magnaldo T, Poirier F (2008) Galectin-7 in the control of epidermal homeostasis after injury. Mol Biol Cell 19:5541–5549. https://doi.org/10.1091/mbc.e08-02-0166
Gendronneau G, Sanii S, Dang T, Deshayes F, Delacour D, Pichard E, Advedissian T, Sidhu SS, Viguier M, Magnaldo T et al (2015) Overexpression of galectin-7 in mouse epidermis leads to loss of cell junctions and defective skin repair. PLoS ONE 10:e0119031–e0119031. https://doi.org/10.1371/journal.pone.0119031
Chen H-L, Lo C-H, Huang C-C, Lu M-P, Hu P-Y, Chen C-S, Chueh D-Y, Chen P, Lin T-N, Lo Y-H et al (2021) Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis. J Clin Invest 131:e130740. https://doi.org/10.1172/JCI130740
Cao Z, Said N, Wu HK, Kuwabara I, Liu F-T, Panjwani N (2003) Galectin-7 as a potential mediator of corneal epithelial cell migration. Arch Ophthalmol 121:82–86. https://doi.org/10.1001/archopht.121.1.82
Kaur M, Kaur T, Kamboj SS, Singh J (2016) Roles of galectin-7 in cancer. Asian Pac J Cancer Prev 17(2):455–461. http://dx.doi.org/10.7314/apjcp.2016.17.2.455
Su J (2018) A brief history of Charcot-Leyden crystal protein/galectin-10 research. Molecules 23:2931. https://doi.org/10.3390/molecules23112931
Than NG, Balogh A, Romero R, Kárpáti E, Erez O, Szilágyi A, Kovalszky I, Sammar M, Gizurarson S, Matkó J et al (2014) Placental protein 13 (PP13)—a placental immunoregulatory galectin protecting pregnancy. Front Immunol 5:348–348. https://doi.org/10.3389/fimmu.2014.00348
Si Y, Li Y, Yang T, Li X, Ayala GJ, Mayo KH, Tai G, Su J, Zhou Y (2021) Structure–function studies of galectin-14, an important effector molecule in embryology. FEBS J 288:1041–1055. https://doi.org/10.1111/febs.15441
Hokama A, Mizoguchi E, Sugimoto K, Shimomura Y, Tanaka Y, Yoshida M, Rietdijk ST, de Jong YP, Snapper SB, Terhorst C et al (2004) Induced reactivity of intestinal CD4+ T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20:681–693. https://doi.org/10.1016/j.immuni.2004.05.009
Chen C, Wang G, Huang X, Dong X, Chen G, Lin M, Cai Z, Zeng Y (2017) Overexpression of galectin-4 promotes cell growth of hepatocellular carcinoma cells in vitro and in vivo. Int J Clin Exp Pathol 10:10233–10242
Hadari YR, Paz K, Dekel R, Mestrovic T, Accili D, Zick Y (1995) Galectin-8: a new rat lectin, related to galectin-4 (∗). J Biol Chem 270:3447–3453. https://doi.org/10.1074/jbc.270.7.3447
Bidon N, Brichory F, Bourguet P, Le Pennec J-P, Dazord L (2001) Galectin-8: a complex sub-family of galectins (review). Int J Mol Med 8:245–250. https://doi.org/10.3892/ijmm.8.3.245
Troncoso MF, Ferragut F, Bacigalupo ML, Cárdenas Delgado VM, Nugnes LG, Gentilini L, Laderach D, Wolfenstein-Todel C, Compagno D, Rabinovich GA et al (2014) Galectin-8: a matricellular lectin with key roles in angiogenesis. Glycobiology 24:907–914. https://doi.org/10.1093/glycob/cwu054
Smith PC, Metz C, de la Peña A, Oyanadel C, Avila P, Arancibia R, Vicuña L, Retamal C, Barake F, González A et al (2020) Galectin-8 mediates fibrogenesis induced by cyclosporine in human gingival fibroblasts. J Periodontal Res 55:724–733. https://doi.org/10.1111/jre.12761
Meinohl C, Barnard SJ, Fritz-Wolf K, Unger M, Porr A, Heipel M, Wirth S, Madlung J, Nordheim A, Menke A et al (2020) Galectin-8 binds to the farnesylated C-terminus of K-Ras4B and modifies Ras/ERK signaling and migration in pancreatic and lung carcinoma cells. Cancers 12. https://doi.org/10.3390/cancers12010030
Wada J, Kanwar YS (1997) Identification and characterization of galectin-9, a novel β-galactoside-binding mammalian lectin*. J Biol Chem 272:6078–6086. https://doi.org/10.1074/jbc.272.9.6078
Zhang W, Zhang Y, He Y, Wang X, Fang Q (2019) Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the tim-3/galectin-9 signalling pathway. Exp Cell Res 376:124–132. https://doi.org/10.1016/j.yexcr.2019.02.007
Thijssen VL, Griffioen AW (2014) Galectin-1 and -9 in angiogenesis: a sweet couple. Glycobiology 24:915–920. https://doi.org/10.1093/glycob/cwu048
Shintaro F, Hirohito M, Hideki K, Kazi R, Toshiro N, Mitsuomi H, Tsutomu M (2013) Galectin-9 in cancer therapy. Recent Pat Endocr, Metab Immune Drug Discovery 7:130–137. https://doi.org/10.2174/1872214811307020006
Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A et al (2017) Cancer therapy due to apoptosis: galectin-9. Int J Mol Sci 18:74. https://doi.org/10.3390/ijms18010074
Hotta K, Funahashi T, Matsukawa Y, Takahashi M, Nishizawa H, Kishida K, Matsuda M, Kuriyama H, Kihara S, Nakamura T et al (2001) Galectin-12, an adipose-expressed galectin-like molecule possessing apoptosis-inducing activity*. J Biol Chem 276:34089–34097. https://doi.org/10.1074/jbc.M105097200
Wan L, Lin H-J, Huang C-C, Chen Y-C, Hsu Y-A, Lin C-H, Lin H-C, Chang C-Y, Huang S-H, Lin J-M et al (2016) Galectin-12 enhances inflammation by promoting M1 polarization of macrophages and reduces insulin sensitivity in adipocytes. Glycobiology 26:732–744. https://doi.org/10.1093/glycob/cww013
Wan L, Yang R-Y, Liu F-T (2018) Galectin-12 in cellular differentiation, apoptosis and polarization. Int J Mol Sci 19:176. https://doi.org/10.3390/ijms19010176
Ho MK, Springer TA (1982) Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol 128:1221
Song L, Tang J-w, Owusu L, Sun M-Z, Wu J, Zhang J (2014) Galectin-3 in cancer. Clin Chim Acta 431:185–191. https://doi.org/10.1016/j.cca.2014.01.019
Cao Z, Said N, Amin S, Wu HK, Bruce A, Garate M, Hsu DK, Kuwabara I, Liu F-T, Panjwani N (2002) Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds*. J Biol Chem 277:42299–42305. https://doi.org/10.1074/jbc.M200981200
Saravanan C, Liu F-T, Gipson IK, Panjwani N (2009) Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin. J Cell Sci 122:3684–3693. https://doi.org/10.1242/jcs.045674
Liu W, Hsu DK, Chen H-Y, Yang R-Y, Carraway KL 3rd, Isseroff RR, Liu F-T (2012) Galectin-3 regulates intracellular trafficking of EGFR through Alix and promotes keratinocyte migration. J Invest Dermatol 132:2828–2837. https://doi.org/10.1038/jid.2012.211
Santucci L, Fiorucci S, Cammilleri F, Servillo G, Federici B, Morelli A (2000) Galectin-1 exerts immunomodulatory and protective effects on concanavalin a–induced hepatitis in mice. Hepatology 31:399–406. https://doi.org/10.1002/hep.510310220
Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y (1999) Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190:385–398. https://doi.org/10.1084/jem.190.3.385
Santucci L, Fiorucci S, Rubinstein N, Mencarelli A, Palazzetti B, Federici B, Rabinovich GA, Morelli A (2003) Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124:1381–1394. https://doi.org/10.1016/S0016-5085(03)00267-1
Ozaki K, Inoue K, Sato H, Iida A, Ohnishi Y, Sekine A, Sato H, Odashiro K, Nobuyoshi M, Hori M et al (2004) Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro. Nature 429:72–75. https://doi.org/10.1038/nature02502
Cecilia L (2010) Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets. Discov Med 9:565–578
Hong S-H, Shin J-S, Chung H, Park C-G (2019) Galectin-4 interaction with CD14 triggers the differentiation of monocytes into macrophage-like cells via the MAPK signaling pathway. Immune Netw 19:e17–e17. https://doi.org/10.4110/in.2019.19.e17
Fukumori T, Takenaka Y, Yoshii T, Kim H-RC, Hogan V, Inohara H, Kagawa S, Raz A (2003) CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Can Res 63:8302
Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim H-RC, Raz A (2002) Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest*. J Biol Chem 277:6852–6857. https://doi.org/10.1074/jbc.M107668200
Yamaoka A, Kuwabara I, Frigeri LG, Liu FT (1995) A human lectin, galectin-3 (epsilon bp/Mac-2), stimulates superoxide production by neutrophils. J Immunol 154:3479
Kuwabara I, Liu FT (1996) Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 156:3939
Bhaumik P, St-Pierre G, Milot V, St-Pierre C, Sato S (2013) Galectin-3 facilitates neutrophil recruitment as an innate immune response to a parasitic protozoa cutaneous infection. J Immunol 190:630. https://doi.org/10.4049/jimmunol.1103197
Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, Hirashima M, Liu F-T (2000) Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 165:2156. https://doi.org/10.4049/jimmunol.165.4.2156
Brancato SK, Albina JE (2011) Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol 178:19–25. https://doi.org/10.1016/j.ajpath.2010.08.003
Karlsson A, Christenson K, Matlak M, Björstad Å, Brown KL, Telemo E, Salomonsson E, Leffler H, Bylund J (2009) Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils. Glycobiology 19:16–20. https://doi.org/10.1093/glycob/cwn104
MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T (2008) Regulation of alternative macrophage activation by galectin-3. J Immunol 180:2650. https://doi.org/10.4049/jimmunol.180.4.2650
Walker JT, Elliott CG, Forbes TL, Hamilton DW (2016) Genetic deletion of galectin-3 does not impair full-thickness excisional skin healing. J Investig Dermatol 136:1042–1050. https://doi.org/10.1016/j.jid.2016.01.014
Cattaneo V, Tribulatti MV, Carabelli J, Carestia A, Schattner M, Campetella O (2014) Galectin-8 elicits pro-inflammatory activities in the endothelium. Glycobiology 24:966–973. https://doi.org/10.1093/glycob/cwu060
Romaniuk Maria A, Tribulatti Maria V, Cattaneo V, Lapponi Maria J, Molinas Felisa C, Campetella O, Schattner M (2010) Human platelets express and are activated by galectin-8. Biochemical Journal 432:535–547. https://doi.org/10.1042/BJ20100538
Carabelli J, Quattrocchi V, D’Antuono A, Zamorano P, Tribulatti MV, Campetella O (2017) Galectin-8 activates dendritic cells and stimulates antigen-specific immune response elicitation. J Leukoc Biol 102:1237–1247. https://doi.org/10.1189/jlb.3A0816-357RR
Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, Hirashima M, Nakamura T (2003) Galectin-8 modulates neutrophil function via interaction with integrin αM. Glycobiology 13:755–763. https://doi.org/10.1093/glycob/cwg102
Choi E, Miller AD, Devenish E, Asakawa M, McConkey M, Peters-Kennedy J (2017) Charcot-Leyden crystals: do they exist in veterinary species? A case report and literature review. J Vet Diagn Invest 29:904–909. https://doi.org/10.1177/1040638717725783
Dvorak AM, Letourneau L, Login GR, Weller PF, Ackerman SJ (1988) Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils. Blood 72:150–158. https://doi.org/10.1182/blood.V72.1.150.150
Rodríguez-Alcázar JF, Ataide MA, Engels G, Schmitt-Mabmunyo C, Garbi N, Kastenmüller W, Latz E, Franklin BS (2019) Charcot-Leyden crystals activate the NLRP3 inflammasome and cause IL-1β inflammation in human macrophages. J Immunol 202:550. https://doi.org/10.4049/jimmunol.1800107
Pang J, Rhodes DH, Pini M, Akasheh RT, Castellanos KJ, Cabay RJ, Cooper D, Perretti M, Fantuzzi G (2013) Increased adiposity, dysregulated glucose metabolism and systemic inflammation in galectin-3 KO mice. PLoS ONE 8:e57915–e57915. https://doi.org/10.1371/journal.pone.0057915
Thijssen VLJL, Postel R, Brandwijk RJMGE, Dings RPM, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J et al (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 103:15975–15980. https://doi.org/10.1073/pnas.0603883103
Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, Ouyang J, Ilarregui JM, Toscano MA, Domaica CI et al (2012) Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma. J Exp Med 209:1985–2000. https://doi.org/10.1084/jem.20111665
Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A (2000) Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156:899–909. https://doi.org/10.1016/S0002-9440(10)64959-0
Delgado VMC, Nugnes LG, Colombo LL, Troncoso MF, Fernández MM, Malchiodi EL, Frahm I, Croci DO, Compagno D, Rabinovich GA et al (2011) Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem-repeat” lectin galectin-8. FASEB J 25:242–254. https://doi.org/10.1096/fj.09-144907
Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, Wong TY, Jin YT, Hong TM, Chen YL (2008) Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27:3746–3753. https://doi.org/10.1038/sj.onc.1211029
Croci DO, Cerliani JP, Dalotto-Moreno T, Mendez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, Garcia-Vallejo JJ, Ouyang J et al (2014) Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 156:744–758. https://doi.org/10.1016/j.cell.2014.01.043
Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, Hackeng TM, Kiss R, Kloog Y, Poirier F et al (2010) Tumor cells secrete galectin-1 to enhance endothelial cell activity. Can Res 70:6216. https://doi.org/10.1158/0008-5472.CAN-09-4150
Wei J, Li DK, Hu X, Cheng C, Zhang Y (2021) Galectin-1–RNA interaction map reveals potential regulatory roles in angiogenesis. FEBS Lett 595:623–636. https://doi.org/10.1002/1873-3468.14047
Wu M-H, Ying N-W, Hong T-M, Chiang W-F, Lin Y-T, Chen Y-L (2014) Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex. Angiogenesis 17:839–849. https://doi.org/10.1007/s10456-014-9431-8
Wu D, Kanda A, Liu Y, Kase S, Noda K, Ishida S (2019) Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelialmesenchymal transition. FASEB J 33:2498–2513. https://doi.org/10.1096/fj.201801227R
Markowska AI, Liu F-T, Panjwani N (2010) Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med 207:1981–1993. https://doi.org/10.1084/jem.20090121
Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K, Wheeler J, Gleave M, Sanghera J, Dedhar S (2004) Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5:79–90. https://doi.org/10.1016/S1535-6108(03)00281-2
Markowska AI, Jefferies KC, Panjwani N (2011) Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. J Biol Chem 286:29913–29921. https://doi.org/10.1074/jbc.M111.226423
Johannes P, Harald FL (2012) Platelets in angiogenesis. Curr Vasc Pharmacol 10:570–577. https://doi.org/10.2174/157016112801784648
Etulain J, Fondevila C, Negrotto S, Schattner M (2013) Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin. Br J Pharmacol 170:255–265. https://doi.org/10.1111/bph.12250
Etulain J, Negrotto S, Tribulatti MV, Croci DO, Carabelli J, Campetella O, Rabinovich GA, Schattner M (2014) Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors. PLoS ONE 9:e96402–e96402. https://doi.org/10.1371/journal.pone.0096402
Spitzenberger F, Graessler J, Schroeder H-E (2001) Molecular and functional characterization of galectin 9 mRNA isoforms in porcine and human cells and tissues***. The nucleotide sequences reported in this paper have been submitted to the GenBankTM / EBI Data Bank with accession number(s) AJ131826 (Sus scrofa mRNA for urate transporter/channel protein) and AJ131827 (Sus scrofa mRNA for urate transporter/channel isoform). Biochimie 83:851–862. https://doi.org/10.1016/S0300-9084(01)01335-9
Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M, Nishi N, Fujimoto K, Tanji K, Shibata T et al (2002) Interferon-γ stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 72:486–491. https://doi.org/10.1189/jlb.72.3.486
Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y, Abedin MJ, Yoshida N, Nishi N, Imaizumi T et al (2002) Selective eosinophil adhesion to fibroblast via IFN-γ-induced galectin-9. J Immunol 169:5912. https://doi.org/10.4049/jimmunol.169.10.5912
Fujii A, Shearer TR, Azuma M (2015) Galectin-3 enhances extracellular matrix associations and wound healing in monkey corneal epithelium. Exp Eye Res 137:71–78. https://doi.org/10.1016/j.exer.2015.06.010
Tracy LE, Minasian RA, Caterson EJ (2016) Extracellular matrix and dermal fibroblast function in the healing wound. Adv Wound Care 5:119–136. https://doi.org/10.1089/wound.2014.0561
Gál P, Varinská L, Fáber L, Novák Š, Szabo P, Mitrengová P, Mirossay A, Mučaji P, Smetana K (2017) How signaling molecules regulate tumor microenvironment: parallels to wound repair. Molecules 22:1818. https://doi.org/10.3390/molecules22111818
Zhang M, Zhang S (2020) T cells in fibrosis and fibrotic diseases. Front Immunol 11:1142–1142. https://doi.org/10.3389/fimmu.2020.01142
Wu M-H, Chen Y-L, Lee K-H, Chang C-C, Cheng T-M, Wu S-Y, Tu C-C, Tsui W-L (2017) Glycosylation-dependent galectin-1/neuropilin-1 interactions promote liver fibrosis through activation of TGF-β- and PDGF-like signals in hepatic stellate cells. Sci Rep 7:11006–11006. https://doi.org/10.1038/s41598-017-11212-1
Kathiriya JJ, Nakra N, Nixon J, Patel PS, Vaghasiya V, Alhassani A, Tian Z, Allen-Gipson D, Davé V (2017) Galectin-1 inhibition attenuates profibrotic signaling in hypoxia-induced pulmonary fibrosis. Cell Death Discov 3:17010–17010. https://doi.org/10.1038/cddiscovery.2017.10
Tang D, Wu Q, Zhang J, Zhang H, Yuan Z, Xu J, Chong Y, Huang Y, Xiong Q, Wang S et al (2018) Galectin-1 expression in activated pancreatic satellite cells promotes fibrosis in chronic pancreatitis/pancreatic cancer via the TGF-β1/Smad pathway. Oncol Rep 39:1347–1355. https://doi.org/10.3892/or.2018.6202
González GE, Cassaglia P, Noli Truant S, Fernández MM, Wilensky L, Volberg V, Malchiodi EL, Morales C, Gelpi RJ (2014) Galectin-3 is essential for early wound healing and ventricular remodeling after myocardial infarction in mice. Int J Cardiol 176:1423–1425. https://doi.org/10.1016/j.ijcard.2014.08.011
Mackinnon AC, Gibbons MA, Farnworth SL, Leffler H, Nilsson UJ, Delaine T, Simpson AJ, Forbes SJ, Hirani N, Gauldie J et al (2012) Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med 185:537–546. https://doi.org/10.1164/rccm.201106-0965OC
Chen S-C, Kuo P-L (2016) The role of galectin-3 in the kidneys. Int J Mol Sci 17:565–565. https://doi.org/10.3390/ijms17040565
Jiang JX, Chen X, Hsu DK, Baghy K, Serizawa N, Scott F, Takada Y, Takada Y, Fukada H, Chen J et al (2012) Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo. Am J Physiol Gastrointest Liver Physiol 302:G439–G446. https://doi.org/10.1152/ajpgi.00257.2011
Seki E, Brenner DA (2015) Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci 22:512–518. https://doi.org/10.1002/jhbp.245
Seki E, Schwabe RF (2015) Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology (Baltimore, MD) 61:1066–1079. https://doi.org/10.1002/hep.27332
Mak KM, Mei R (2017) Basement membrane type IV collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease. Anat Rec 300:1371–1390. https://doi.org/10.1002/ar.23567
Wu L, Luo Z, Zheng J, Yao P, Yuan Z, Lv X, Zhao J, Wang M (2018) IL-33 can promote the process of pulmonary fibrosis by inducing the imbalance between MMP-9 and TIMP-1. Inflammation 41:878–885. https://doi.org/10.1007/s10753-018-0742-6
Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448–464. https://doi.org/10.1002/path.1400
Maeda N, Kawada N, Seki S, Arakawa T, Ikeda K, Iwao H, Okuyama H, Hirabayashi J, Kasai K-i, Yoshizato K (2003) Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways*. J Biol Chem 278:18938–18944. https://doi.org/10.1074/jbc.M209673200
Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17:113–125. https://doi.org/10.2119/molmed.2009.00153
Pohlers D, Brenmoehl J, Löffler I, Müller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G (2009) TGF-β and fibrosis in different organs — molecular pathway imprints. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1792:746–756. https://doi.org/10.1016/j.bbadis.2009.06.004
Kirkpatrick LD, Shupp JW, Smith RD, Alkhalil A, Moffatt LT, Carney BC (2021) Galectin-1 production is elevated in hypertrophic scar. Wound Repair and Regeneration: Official Publication of the Wound Healing Society [and] the European Tissue Repair Society 29:117–128. https://doi.org/10.1111/wrr.12869
Ong CT, Khoo YT, Mukhopadhyay A, Masilamani J, Do DV, Lim IJ, Phan TT (2010) Comparative proteomic analysis between normal skin and keloid scar. Br J Dermatol 162:1302–1315. https://doi.org/10.1111/j.1365-2133.2010.09660.x
Yanaba K, Asano Y, Akamata K, Noda S, Aozasa N, Taniguchi T, Takahashi T, Toyama T, Ichimura Y, Sumida H et al (2016) Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy. Int J Rheum Dis 19:622–627. https://doi.org/10.1111/1756-185X.12288
Gál P, Vasilenko T, Kostelníková M, Jakubco J, Kovác I, Sabol F, André S, Kaltner H, Gabius H-J, Smetana K Jr (2011) Open wound healing in vivo: monitoring binding and presence of adhesion/growth-regulatory galectins in rat skin during the course of complete re-epithelialization. Acta Histochem Cytochem 44:191–199. https://doi.org/10.1267/ahc.11014
Ho S, Marçal H, Foster LJR (2014) Towards scarless wound healing: a comparison of protein expression between human, adult and foetal fibroblasts. Biomed Res Int 2014:676493–676493. https://doi.org/10.1155/2014/676493
Camby I, Le Mercier M, Lefranc F, Kiss R (2006) Galectin-1: a small protein with major functions. Glycobiology 16:137R-157R. https://doi.org/10.1093/glycob/cwl025
Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, Haslett C, Simpson KJ, Sethi T (2006) Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A 103:5060–5065. https://doi.org/10.1073/pnas.0511167103
Luo H, Liu B, Zhao L, He J, Li T, Zha L, Li X, Qi Q, Liu Y, Yu Z (2017) Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension. J Am Soc Hypertens 11:673-683.e673. https://doi.org/10.1016/j.jash.2017.07.009
Mazurek JA, Horne BD, Saeed W, Sardar MR, Zolty R (2017) Galectin-3 levels are elevated and predictive of mortality in pulmonary hypertension. Heart Lung Circ 26:1208–1215. https://doi.org/10.1016/j.hlc.2016.12.012
He J, Li X, Luo H, Li T, Zhao L, Qi Q, Liu Y, Yu Z (2017) Galectin-3 mediates the pulmonary arterial hypertension–induced right ventricular remodeling through interacting with NADPH oxidase 4. J Am Soc Hypertens 11:275-289.e272. https://doi.org/10.1016/j.jash.2017.03.008
Tang H, Zhang P, Zeng L, Zhao Y, Xie L, Chen B (2021) Mesenchymal stem cells ameliorate renal fibrosis by galectin-3/Akt/GSK3β/Snail signaling pathway in adenine-induced nephropathy rat. Stem Cell Res Ther 12:409–409. https://doi.org/10.1186/s13287-021-02429-z
Akimoto Y, Ikehara S, Yamaguchi T, Kim J, Kawakami H, Shimizu N, Hori M, Sakakita H, Ikehara Y (2016) Galectin expression in healing wounded skin treated with low-temperature plasma: comparison with treatment by electronical coagulation. Arch Biochem Biophys 605:86–94. https://doi.org/10.1016/j.abb.2016.01.012
Manzi M, Bacigalupo ML, Carabias P, Elola MT, Wolfenstein-Todel C, Rabinovich GA, Espelt MV, Troncoso MF (2016) Galectin-1 controls the proliferation and migration of liver sinusoidal endothelial cells and their interaction with hepatocarcinoma cells. J Cell Physiol 231:1522–1533. https://doi.org/10.1002/jcp.25244
van Beijnum JR, Thijssen VL, Läppchen T, Wong TJ, Verel I, Engbersen M, Schulkens IA, Rossin R, Grüll H, Griffioen AW et al (2016) A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies. Int J Cancer 139:824–835. https://doi.org/10.1002/ijc.30131
PerŽEĽOvÁ V, VarinskÁ L, DvoŘÁNkovÁ B, Szabo P, SpurnÝ P, Valach J, MojŽIŠ J, AndrÉ S, Gabius H-J, Smetana K et al (2014) Extracellular matrix of galectin-1-exposed dermal and tumor-associated fibroblasts favors growth of human umbilical vein endothelial cells in vitro: a short report. Anticancer Res 34:3991
Salajegheh A, Dolan-Evans E, Sullivan E, Irani S, Rahman MA, Vosgha H, Gopalan V, Smith RA, Lam AK-Y (2014) The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression. Exp Mol Pathol 96:212–218. https://doi.org/10.1016/j.yexmp.2014.02.003
Freichel T, Heine V, Laaf D, Mackintosh EE, Sarafova S, Elling L, Snyder NL, Hartmann L (2020) Sequence-defined heteromultivalent precision glycomacromolecules bearing sulfonated/sulfated nonglycosidic moieties preferentially bind galectin-3 and delay wound healing of a galectin-3 positive tumor cell line in an in vitro wound scratch assay. Macromol Biosci 20:2000163. https://doi.org/10.1002/mabi.202000163
Chen C, Duckworth CA, Fu B, Pritchard DM, Rhodes JM, Yu LG (2014) Circulating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis. Br J Cancer 110:741–752. https://doi.org/10.1038/bjc.2013.793
Cai Z, Zeng Y, Xu B, Gao Y, Wang S, Zeng J, Chen L, Huang A, Liu X, Liu J (2014) Galectin-4 serves as a prognostic biomarker for the early recurrence/metastasis of hepatocellular carcinoma. Cancer Sci 105:1510–1517. https://doi.org/10.1111/cas.12536
Acknowledgements
The authors acknowledge the administrative support of The Affiliated Hospital of Yangzhou University. We would like to thank the native English-speaking scientists of Editeg Company (Shanghai, China) for editing our manuscript.
Funding
This work was supported in part by the National Natural Science Foundation of China (No. 81802792).
Author information
Authors and Affiliations
Contributions
D.Y., M.B., P.Y., and Y.C. conceived and designed the study. D.Y. and Y.C. drafted the manuscript. D.Y., Y.P.L., and. Y.C. drew the table and figures. All the authors were involved in revising the paper critically and gave final approval of the version to be submitted. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yu, D., Bu, M., Yu, P. et al. Regulation of wound healing and fibrosis by galectins. J Mol Med 100, 861–874 (2022). https://doi.org/10.1007/s00109-022-02207-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-022-02207-1